These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
1/4/2017
7:30 AM ET
Press Release

Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference

1/4/2017

WALTHAM, Mass., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at...

 Continue Reading
12/15/2016
7:41 AM ET
Press Release

UPDATE -- Repligen Acquires TangenX Technology Corporation

12/15/2016

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired Tan...

 Continue Reading
11/7/2016
11:27 AM ET
Press Release

Repligen to Participate in Stephens Inc. Fall Investment Conference 2016

11/7/2016

WALTHAM, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs,...

 Continue Reading
11/3/2016
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2016 Financial Results

11/3/2016

WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the...

 Continue Reading
10/20/2016
7:30 AM ET
Press Release

Repligen to Report Third Quarter 2016 Financial Results

10/20/2016

WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report third quarter 2016 financial results on Thursday, November 3, 2016....

 Continue Reading
Displaying 1 to 5 (of 188 releases)